Financial results - BIOTEK TECHNOLOGIES SRL

Financial Summary - Biotek Technologies Srl
Unique identification code: 33290890
Registration number: J02/655/2014
Nace: 161
Sales - Ron
61.777
Net Profit - Ron
16.450
Employee
2
The most important financial indicators for the company Biotek Technologies Srl - Unique Identification Number 33290890: sales in 2017 was 61.777 euro, registering a net profit of 16.450 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati auxiliare pentru productia vegetala having the NACE code 161.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Biotek Technologies Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 10.340 83.936 94.301 66.894 - - - - - -
Total Income - EUR 10.340 83.937 94.358 77.691 - - - - - -
Total Expenses - EUR 4.941 10.309 49.173 59.102 - - - - - -
Gross Profit/Loss - EUR 5.399 73.627 45.185 18.589 - - - - - -
Net Profit/Loss - EUR 5.089 71.038 44.242 17.812 - - - - - -
Employees 0 0 2 2 - - - - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -27.8%, from 94.301 euro in the year 2016, to 66.894 euro in 2017. The Net Profit decreased by -25.681 euro, from 44.242 euro in 2016, to 17.812 in the last year.

Check the financial reports for the company - Biotek Technologies Srl

Rating financiar

Financial Rating -
Biotek Technologies Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Biotek Technologies Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biotek Technologies Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Biotek Technologies Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biotek Technologies Srl - CUI 33290890

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 1.388 14.434 1.493 - - - - - -
Current Assets 5.443 81.948 127.909 34.533 - - - - - -
Inventories 0 0 3.178 313 - - - - - -
Receivables 1.896 22.808 90.263 21.501 - - - - - -
Cash 3.547 59.140 34.469 12.719 - - - - - -
Shareholders Funds 5.133 76.214 46.641 20.209 - - - - - -
Social Capital 45 45 45 55 - - - - - -
Debts 310 7.121 95.852 2.739 - - - - - -
Income in Advance 0 0 68.570 13.143 - - - - - -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "161 - 161"
CAEN Financial Year 161
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 34.533 euro in 2017 which includes Inventories of 313 euro, Receivables of 21.501 euro and cash availability of 12.719 euro.
The company's Equity was valued at 20.209 euro, while total Liabilities amounted to 2.739 euro. Equity decreased by -25.643 euro, from 46.641 euro in 2016, to 20.209 in 2017. The Debt Ratio was 7.6% in the year 2017.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Biotek Technologies Srl

Comments - Biotek Technologies Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.